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Angiogenesis is essential for tumor growth, 1 and it has been
shown that anti-angiogenic therapy has been proven to be effective in several cancers such as colorectal cancer 2, 3 and hepatocellular carcinoma (HCC). 4 Currently available antiangiogenic cancer chemotherapy targets the vascular endothelial growth factor (VEGF) pathway by VEGF monoclonal antibody (bevacizumab) 3 or multi-targeted receptor tyrosine kinase inhibitors (sorafenib). 4 Hypoxia-inducible factor 1 (HIF-1) is a heterodimer protein which is composed of oxygen-regulated HIF-1α subunit and constitutively expressed HIF-1β subunit. 5, 6 Under normoxic condition, the degradation of HIF-1α subunit is facilitated by ubiquitination following the hydroxylation of proline residue(s). However, under hypoxic condition, stability of HIF-1α increases due to suppressed proline hydroxylation, leading to increased transcription of genes associated with adaptive homeostatic response to hypoxia such as erythropoiesis, glucose metabolism and angiogenesis. 7 In addition to intratumoral hypoxia, loss of function of tumor-suppressor genes also contributes to over-expression of HIF-1α in various human cancers. 6 HIF-1 is a key regulatory factor for angiogenesis in response to hypoxia: it induces expression of angiogenic growth factors such as VEGF, stromal derived factor 1, angiopoietin 2, placental growth factor, platelet-derived growth factor B and stem cell factor. 8 Many human cancers over-express HIF-1α, and expression of HIF-1α is associated with poor prognosis. antisense oligonucleotide. 12 In the current study, however, the mechanisms by which HIF-1α directly inhibits the proliferation of hepatoma cell lines were not examined. In hypoxic state, HIF-1 can either induce or inhibit apoptosis. 13 Moreover, a recent report shows that knock-down of HIF-1α causes reciprocal increase of HIF-2α and vice versa, leading to attenuated apoptosis in HepG2 cells. 14 subcutaneous HCC model. 16 However, two reports assessing the effect of HIF-1α on the tumor growth in orthotopic hepatoma models showed conflicting results. 17, 18 These results imply that the action of HIF-1 may be influenced by the types of tumor cells and/or the stromal components of the tumor. 9 Further animal studies are also warranted to examine the efficacy of combination therapy that includes HIF-1α targeting and conventional types of anti-cancer drugs.
